AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,68 $
arrow_downward
-0,70%(-0,21) 1D
29,68 $
0,00% (0,00)
bedtimeAfter hours
Closed: 18 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,57 $
High
30,48 $
Low
29,22 $
Mkt. cap
1,78 մլրդ
Avg. vol.
1,21 մլն
Volume
593,20 հզր
52-wk high
44,07 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
Open
29,57 $
High
30,48 $
Low
29,22 $
Mkt. cap
1,78 մլրդ
Avg. vol.
1,21 մլն
Volume
593,20 հզր
52-wk high
44,07 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
News stories
From web sources and news partners
Barron's
·
56 րոպե առաջ
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
BigGo Finance
·
2 ժամ առաջ
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
FOREX.com
·
1 ժամ առաջ
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Traders Union
·
1 ժամ առաջ
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc